ARCHIVES

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

This article is from The Cancer Letter archive.

Vol. 05 No. 01 | January 5, 1979

Download PDF Visit The Full Archive

Related Articles

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Consortium Centers Pose Problems To Some, But claim They “Coincide With Congress’ Intent”

December 9, 1977

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

California Land Control Grant, Need Administrator

April 21, 1978

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991